ArticleBritish journal of cancer2010

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

M T de Bruijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.